10.05
price down icon2.05%   -0.21
pre-market  Pre-market:  10.87   0.82   +8.16%
loading

Mineralys Therapeutics Inc Stock (MLYS) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
27.61%
35.36
27.71 26.27 15.73 14.94
Operating Income/Loss
27.61%
-35.36
-27.71 -26.27 -15.73 -14.94
Nonoperating Income/Loss
16.01%
3.854
3.322 3.513 3.594 2.33
Income/Loss From Continuing Operations Before Tax
29.19%
-31.51
-24.39 -22.76 -12.14 -12.61
Income/Loss From Continuing Operations After Tax
29.19%
-31.51
-24.39 -22.76 -12.14 -12.61
Net Income/Loss
29.19%
-31.51
-24.39 -22.76 -12.14 -12.61
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
3,312%
44.90
1.316 39.93 39.75 24.76
Diluted Average Shares
3,312%
44.90
1.316 39.93 39.75 24.76
Basic Earnings Per Share
11.11%
-0.70
-0.63 -0.57 -0.31 -0.51
Diluted Earnings Per Share
11.11%
-0.70
-0.63 -0.57 -0.31 -0.51
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):